The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Muscular Dystrophy with Neurologic Involvement

Advanced evaluation of dystrophic diseases with neurologic involvement

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Muscular Dystrophy with Neurologic Involvement?

Several muscular dystrophies extend beyond skeletal muscle to involve the central nervous system creating complex multisystem disorders. Dystrophinopathies including Duchenne and Becker muscular dystrophy result from dystrophin gene mutations and may present with cognitive impairment learning disabilities and autism spectrum features in significant proportion of patients. Brain dystrophin isoforms underlie this neurologic involvement.

Myotonic dystrophy type 1 caused by CTG repeat expansion in the DMPK gene presents with multisystem involvement including muscle weakness myotonia cataracts cardiac conduction abnormalities and prominent central nervous system features. Cognitive dysfunction excessive daytime sleepiness apathy and white matter abnormalities are characteristic. Severity correlates with repeat length particularly in congenital form. FKRP related dystroglycanopathies cause varying brain involvement from severe lissencephaly type cobblestone cortex to milder cognitive impairment.

Evaluation requires multidisciplinary approach including neurology genetics cardiology pulmonology and developmental specialists. Brain MRI identifies structural abnormalities including cortical malformations white matter changes and atrophy. Neuropsychological assessment guides educational and behavioral interventions. Cardiac evaluation including echocardiography and rhythm monitoring is essential as cardiac involvement contributes significantly to morbidity and mortality. Genetic counseling helps families understand inheritance patterns and reproductive options. Emerging therapies including exon skipping for Duchenne and antisense oligonucleotides offer new treatment options requiring specialized centers.

Symptoms

Progressive muscle weakness
Cognitive impairment varying severity
Cardiac conduction abnormalities
Cataracts in myotonic dystrophy
Behavioral and developmental features

Risk Factors

Family history of muscular dystrophy
Genetic mutation inheritance
X linked transmission for dystrophinopathies
Autosomal dominant for myotonic dystrophy type 1
Founder mutations in specific populations

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When muscle weakness is progressive
  • When developmental concerns coexist with weakness
  • When family history suggests muscular dystrophy
  • When cardiac symptoms develop

Treatment Methods

01
Multidisciplinary specialist team coordination
02
Brain MRI for structural assessment
03
Neuropsychological evaluation
04
Cardiac monitoring with echocardiography and ECG
05
Genetic counseling and testing
06
Emerging targeted therapies in specialized centers

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.